Thus, EGCG may alleviate anxiety and depression-like behaviors in mice by downregulating Sema3A and increasing GSK3β phosphorylation in the hippocampus, and has potential application in the treatment of PPD. This evidence concerns the gene GSK3B and progressive pseudorheumatoid arthropathy of childhood.